AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $124,000 | -20.0% | 10,500 | 0.0% | 0.06% | -25.3% |
| Q2 2020 | $155,000 | +9.2% | 10,500 | 0.0% | 0.08% | -6.0% |
| Q1 2020 | $142,000 | -44.1% | 10,500 | 0.0% | 0.08% | -25.0% |
| Q4 2019 | $254,000 | +25.7% | 10,500 | 0.0% | 0.11% | +27.3% |
| Q3 2019 | $202,000 | -34.8% | 10,500 | 0.0% | 0.09% | -36.7% |
| Q2 2019 | $310,000 | -37.9% | 10,500 | 0.0% | 0.14% | -39.0% |
| Q1 2019 | $499,000 | +31.7% | 10,500 | 0.0% | 0.23% | +0.4% |
| Q4 2018 | $379,000 | -41.3% | 10,500 | 0.0% | 0.23% | -38.1% |
| Q3 2018 | $646,000 | -8.9% | 10,500 | 0.0% | 0.37% | +2.2% |
| Q2 2018 | $709,000 | +24.4% | 10,500 | 0.0% | 0.36% | +18.9% |
| Q1 2018 | $570,000 | -9.1% | 10,500 | 0.0% | 0.30% | -5.6% |
| Q4 2017 | $627,000 | -30.3% | 10,500 | -43.2% | 0.32% | -34.6% |
| Q3 2017 | $899,000 | -7.5% | 18,500 | 0.0% | 0.49% | -14.5% |
| Q2 2017 | $972,000 | +15.9% | 18,500 | 0.0% | 0.57% | +6.9% |
| Q1 2017 | $839,000 | +10.8% | 18,500 | -7.5% | 0.54% | -2.7% |
| Q4 2016 | $757,000 | +0.3% | 20,000 | 0.0% | 0.55% | -18.2% |
| Q3 2016 | $755,000 | +114.5% | 20,000 | 0.0% | 0.67% | +149.8% |
| Q2 2016 | $352,000 | +44.9% | 20,000 | 0.0% | 0.27% | +61.1% |
| Q1 2016 | $243,000 | -50.1% | 20,000 | 0.0% | 0.17% | -51.7% |
| Q4 2015 | $487,000 | – | 20,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |